Approved: will have earnings.
Nothing approved: will have more dilution
Go with approved.
A glitzy website is a selling point for you?
Are you a 13 year old girl?
Wow! ,,,,, Every single partner terminated the agreement.
What does that tell you?
Now that's a stock!
Look at the market cap of EXAS and they are further behind GTHP.
A very good chance of at least a 10 bagger.
Look at the market cap of EXAS and they are further behind.
He must have listened to the Kimmie presentation of "nothing in Phase 3 for over 34 years"
or is it the SA pumper taking a massive dump on the baggies faces now?
The biophotonics scan is more accurate and provides instant test results.
It's already approved in Asia, EU, Mid East and Canada.
The market cap is only $30M!!!
Look for a 10 bagger in 2014.
"The buprenorphine sustained release delivery system provides in situ 1-month and 3-month release profiles characterized by an exceptionally high bioavailability and minimal risk of permanent tissue damage and typically no risk of muscle necrosis.'
3-months is 3 months.